Your browser doesn't support javascript.
loading
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.
Morris, Gerwyn; Walder, Ken; Kloiber, Stefan; Amminger, Paul; Berk, Michael; Bortolasci, Chiara C; Maes, Michael; Puri, Basant K; Carvalho, Andre F.
Affiliation
  • Morris G; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
  • Walder K; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia; Deakin University, Centre for Molecular and Medical Research, School of Medicine, Geelong, Australia.
  • Kloiber S; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 33 Ursula Franklin Street, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Amminger P; Orygen, Parkville, Victoria, Australia; Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Berk M; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Hea
  • Bortolasci CC; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia.
  • Maes M; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia; Department of Psychiatry, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Department of Psychiatry, Medical Universi
  • Puri BK; Cambridge Advanced Research (C.A.R.), Cambridge, UK.
  • Carvalho AF; Deakin University, IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia. Electronic address: andrefc7@hotmail.com.
Pharmacol Res ; 170: 105729, 2021 08.
Article in En | MEDLINE | ID: mdl-34119623
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain / Neurodegenerative Diseases / Receptor, Cannabinoid, CB1 / Receptor, Cannabinoid, CB2 / Endocannabinoids / Neuroinflammatory Diseases / Mental Disorders Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2021 Type: Article Affiliation country: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Brain / Neurodegenerative Diseases / Receptor, Cannabinoid, CB1 / Receptor, Cannabinoid, CB2 / Endocannabinoids / Neuroinflammatory Diseases / Mental Disorders Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2021 Type: Article Affiliation country: Australia